CONTACT US   |  (864) 397-5101

Biden Administration Publishes Unified Agenda, Revealing FDA’s Planned Regulatory Actions for 2023

Christopher Hanson article

The Unified Agenda is a helpful tool in identifying upcoming opportunities for industry to submit public comments on Advance Notices of Proposed Rulemaking (ANPRs) as well as proposed rules and to plan any additional advocacy activities. The Unified Agenda also alerts the public to when FDA intends to finalize a particular rulemaking, enabling industry to anticipate potential new regulatory requirements.


Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.